Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection
Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection
___
- 1. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:145-147. [Crossref]
- 2. Stephens DM, Spurgeon SE. Ibrutinib in mantle cell lymphoma patients: glass half full? Evidence and opinion. Ther Adv Hematol. 2015;6(5):242-252. [Crossref]
- 3. Roschewski M, Lionakis MS, Sharman JP, et al. Inhibition of Bruton tyrosine kinase in patients with severe COVID-19. Sci Immunol. 2020;5(48):eabd0110. [Crossref]
- 4. Owen C, Berinstein NL, Christofides A, Sehn LH. Review of Bruton tyrosine kinase inhibitors for the treatment of relapsed or refractory mantle cell lymphoma. Curr Oncol. 2019;26(2):e233-e240. [Crossref]
- ISSN: 2146-3123
- Başlangıç: 2015
- Yayıncı: Erkan Mor
A new angiographic finding: primary peripheral slow flow
Ercan AKŞİT, Fatih AYDIN, Emine GAZİ, Bahadır KIRILMAZ
Rediscovery of a forgotten disease: Hereditary Angioedema
Okan GÜLBAHAR, Anastasios E. GERMENIS
A case of intussusception caused by diffuse large B cell lymphoma in ileocecal region
Wen ZHANG, Shuaiyang ZHOU, Zhenguo QIAO, Jianzhong WU, Zhi ZHANG
Pathophysiology and underlying mechanisms in hereditary angioedema
Yankı YAZGAN, Ömer AYDEMİR, Neşe YORGUNER, Serkut BULUT, Herdem ASLAN GENÇ, Gresa CARKACHIU BULUT
Cause-of-death distributions and mortality trends in Turkey between 2009 and 2017
Gül ERGÖR, Ayşe Gülsen TEKER, Ahmet Naci EMECEN
Bilateral choanal polyps originating from the inferior concha
Emergence of multidrug-resistant and -hypervirulent Streptococcus agalactiae in Bulgarian patients
Raina TZVETANOVA GERGOVA, Adile MUHTAROVA, Virna Maria TSITOU, Ivan MITOV
Primary renal neuroblastoma mimicking Wilms’ tumor
Tuba EREN, Vedat AKÇAER, Ebru TAŞTEKİN
Prognostic factors in patients undergoing pulmonary resection for sarcomatoid carcinomas of the lung
Yasemin ÖZLÜK, Dilek YILMAZBAYHAN, Murat KARA, Berk ÇİMENOĞLU, Berker ÖZKAN, Eren ERDOĞDU, Salih DUMAN, Fahmin AMIROV, Alper TOKER